On November 10, 2020 ESSA Pharma Inc. (Nasdaq: EPIX) ("ESSA" or the "Company"), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer reported the Company will be presenting at the Stifel 2020 Virtual Healthcare Conference and Jefferies Virtual London Healthcare Conference (Press release, ESSA, NOV 10, 2020, View Source [SID1234570645]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dr. David. R. Parkinson, Chief Executive Officer, will present a corporate overview of the Company’s business. Dr. Parkinson along with ESSA’s Chief Operating Officer, Peter Virsik, and Chief Financial Officer, David S. Wood will be available for one-on-one meetings from November 16 to 19, 2020.

The presentations will be webcast live and can be accessed through the Investor Relations page at www.essapharma.com. A replay of the presentations will be available on the Company’s website for 90 days.

Stifel 2020 Virtual Healthcare Conference
Presentation Date: Monday, November 16, 2020
Presentation Time: 11:00am Pacific / 2:00pm Eastern

Jefferies Virtual London Healthcare Conference
Presentation Date: Thursday, November 19, 2020
Presentation Time: 10:45am Pacific / 1:45pm Eastern